Unknown

Dataset Information

0

Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.


ABSTRACT: Enkephalin analogues with a 4-anilidopiperidine scaffold have been designed and synthesized to achieve therapeutic benefit for the treatment of pain due to mixed mu and delta opioid agonist activities. Ligand 16, in which a Dmt-substituted enkephalin-like structure was linked to the N-phenyl-N-piperidin-4-yl propionamide moiety, showed very high binding affinities (0.4 nM) at mu and delta receptors with an increased hydrophobicity (aLogP = 2.96). This novel lead compound was found to have very potent agonist activities in MVD (1.8 nM) and GPI (8.5 nM) assays.

SUBMITTER: Lee YS 

PROVIDER: S-EPMC2678914 | biostudies-literature | 2007 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.

Lee Yeon Sun YS   Petrov Ravil R   Park Chad K CK   Ma Shou-wu SW   Davis Peg P   Lai Josephine J   Porreca Frank F   Vardanyan Ruben R   Hruby Victor J VJ  

Journal of medicinal chemistry 20071010 22


Enkephalin analogues with a 4-anilidopiperidine scaffold have been designed and synthesized to achieve therapeutic benefit for the treatment of pain due to mixed mu and delta opioid agonist activities. Ligand 16, in which a Dmt-substituted enkephalin-like structure was linked to the N-phenyl-N-piperidin-4-yl propionamide moiety, showed very high binding affinities (0.4 nM) at mu and delta receptors with an increased hydrophobicity (aLogP = 2.96). This novel lead compound was found to have very p  ...[more]

Similar Datasets

| S-EPMC4698909 | biostudies-literature
| S-EPMC2919913 | biostudies-literature
| S-EPMC8718112 | biostudies-literature
| S-EPMC8629795 | biostudies-literature
| S-EPMC7042108 | biostudies-literature
| S-EPMC5560394 | biostudies-other